# Induction of Migraine Aura With Sildenafil

> **NCT02795351** · EARLY_PHASE1 · COMPLETED · sponsor: **Herlev Hospital** · enrollment: 16 (actual)

## Conditions studied

- Migraine With Aura

## Interventions

- **DRUG:** Sildenafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02795351
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2021-02
- **Final completion:** 2021-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02795351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02795351, "Induction of Migraine Aura With Sildenafil". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02795351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*